Aurora Cannabis Acquires US Based CBD Company Reliva

In its latest “cost-cutting” move, Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced after today’s closing bell that it will be acquiring US based hemp operator Reliva, LLC. The transaction is to take the form of an all-share payout, with Aurora paying US$40 million for the firm.

Details on the transaction were slim, aside from knowing what price is ultimately being paid in the form of shares. It’s unclear what price per share that the associated shares will be issued at, and therefore, its unclear what dilution is expected from the transaction following Aurora’s recent share rollback. What is known, is that earn-out terms have been included in the transaction, with up to $45 million in additional payouts, either in the form of cash or common shares, to be made over the next two years based on financial targets.

Reliva, as per Aurora Cannabis, is a leader in hemp-derived CBD product sales within the US, and reportedly ranks #1 in topical and #2 in overall market share within the US. It’s been stated that the company has products in over 20,000 retail locations, and has contracts with 8 of the 20 leading national retailers. Further, the company is stated to have posted positive EBITDA over the last twelve months, although no hard figures were provided, while being debt free and requiring no further capital expenditures or working capital.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Revenues or sales figures were not provided for Reliva.

Furthermore, Reliva’s CEO, Miguel Martin, is expected to stay with the firm and take the role of President of Aurora USA. Martin has over 25 years within the CPG industry, with previous roles including that of senior VP and General Manager of Altria Sales and Distribution.

The transaction is anticipated to close in June 2020.

Aurora Cannabis last traded at $12.75 on the NYSE. At current price levels, that would peg dilution for the announced transaction at approximately 3.14 million shares.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Aurora Cannabis Posts Declining Q4 2021 Revenues Of $54.8 Million, Net Loss

Aurora Cannabis (TSX: ACB) this afternoon reported its fourth quarter financial results. The firm reported...

Monday, September 27, 2021, 06:16:23 PM

Aurora Exports $10 Million In Cannabis To Israel

Aurora Cannabis (TSX: ACB) seemingly remains focused on growing its international medical cannabis operation. The...

Tuesday, January 4, 2022, 08:07:20 AM

PI Financial Lowers Price Target on Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) saw PI Financial lower its price target today after...

Thursday, September 12, 2019, 06:03:52 PM

Aurora Cannabis Files US$500 Million Base Shelf Prospectus, Reveals ATM Largely Complete

Aurora Cannabis (TSX: ACB) (NYSE: ACB) appears to be in need of money again. The...

Tuesday, October 27, 2020, 12:07:15 AM

Aurora Cannabis Halted, Booth’s Departure Rumoured

Aurora Cannabis (TSX: ACB) (NYSE: ACB) is currently halted pending news from the company. The...

Thursday, February 6, 2020, 02:04:39 PM